Palmoplantar pustulosishttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Palmoplantar pustulosis est longus recurrens pustulare dermatosis (id est pustulosis vel pustularis psorias) in palmis et plantis tantum locata, histologice per intraepidermalibus pusulis neutrophillis repleta. Usus retinoidum systemicorum solus et in compositione cum photochemotherapy ad meliorem symptomata palmoplantar pustulosis.

Curatio
Oral acitretin efficax est ad hoc genus psoriasis.
#Acitretin
☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
  • In hoc casu etiam suspicari potest pompholyx.
  • In absentia pustularum manus scabie potest etiam considerari ut diagnosis differentialis.
References Palmoplantar Psoriasis 28846363 
NIH
Palmoplantar psoriasis Psoriasis genus est quod maxime cutem in palmis et plantis impingit. Pellem densatam ostendit vel arida vel pustula vel permixta utriusque speciei.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).